Shares of Fibrocell Science Inc (NASDAQ:FCSC) saw unusually-strong trading volume on Monday . Approximately 31,266,320 shares traded hands during mid-day trading, an increase of 3,847% from the previous session’s volume of 792,110 shares.The stock last traded at $2.54 and had previously closed at $1.78.
A number of research analysts have weighed in on FCSC shares. Zacks Investment Research lowered shares of Fibrocell Science from a “buy” rating to a “hold” rating in a research note on Monday, February 4th. HC Wainwright reaffirmed a “buy” rating and issued a $22.00 price objective on shares of Fibrocell Science in a research note on Thursday, March 28th. Finally, ValuEngine raised shares of Fibrocell Science from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd.
The company has a market cap of $21.57 million, a price-to-earnings ratio of -1.46 and a beta of 1.59.
A hedge fund recently raised its stake in Fibrocell Science stock. Renaissance Technologies LLC lifted its position in shares of Fibrocell Science Inc (NASDAQ:FCSC) by 126.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 367,941 shares of the company’s stock after purchasing an additional 205,660 shares during the period. Renaissance Technologies LLC owned 3.95% of Fibrocell Science worth $868,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 27.75% of the company’s stock.
About Fibrocell Science (NASDAQ:FCSC)
Fibrocell Science, Inc, an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin and connective tissues in the United States. The company's gene therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, a gene therapy for localized scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions.
Featured Story: How do candlesticks reflect price movement?
Receive News & Ratings for Fibrocell Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fibrocell Science and related companies with MarketBeat.com's FREE daily email newsletter.